Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

On May 23 and 24, 2019, the world's leading fibrosis and cancer researchers met in Bergen at an international fibrosis conference on the topic "New tools to study the fibrotic stroma".
The CCBIO Annual Report 2018 is now available!
World leading cancer experts met at Solstrand: International top notch cancer researchers met at Solstrand to present their work at CCBIO's annual symposium.
Verdensledende kreftforskere møttes på Solstrand for å presentere sin forskning under CCBIOs årlige symposium.
In February, the first CCBIO INTPART long course – CCBIO907 Cancer-Related Vascular Biology – was completed with the final of three course weeks. Assistant Professors Diane Bielenberg, Vascular Biology Program, Boston Children ‘s Hospital, and Magali Saint-Geniez, Schepens Eye Research Institute of Mass. Eye and Ear, Department of Ophthalmology, Harvard Medical School, lectured and tutored the... Read more
A lecture on how to implement career development in PhD-training in the future.
A workshop on careers options, strategies & tactics for life scientists
The University of Bergen has just implemented the Hyperion Imaging System, next generation immunohistochemistry where researchers can explore tissue biology with 35 antibodies simultaneously. This instrument is the only of its kind in Northern Europe, and is open for booking for all researchers on equal terms.
The Research Council of Norway has announced that 11 out of 87 received applications have been selected for funding in their programme called "High-quality and Reliable Diagnostics, Treatment and Rehabilitation (BEHANDLING)”. The project “Enhanced cryoimmunotherapy against urogenital cancers” by project leader Karl-Henning Kalland, CCBIO PI, was among the 11 selected projects and was one of two... Read more
The Norwegian Research Council and other European research councils are about to make a radical alteration of the scientific publishing model by forcing Open Access for all scientific work. The scheme is called Plan S. 27 Norwegian research leaders, including CCBIO Director Lars A. Akslen, suggest changes to improve the European Plan S Open Access scheme.
CCBIO PhD Candidate Hilde Engerud in the Gynecologic Cancer Research Group was awarded with Best Presentation at the annual meeting of the Norwegian Society for Gynecology and Obstetrics this fall, October 25 and 26 2018.
CCBIO Associate Investigator Daniela Elena Costea received support for 3 years (4.5 milion kr) from Western Norway Regional Health Authority (Helse Vest) for the project "Defining molecular subtypes of head and neck cancer by integrative mutational, stromal and inflammatory landscape analysis".
CCBIO Associate Investigator Dana Costea is currently on a sabbatical at Moores Cancer Center at the University of California, San Diego, and reports of a great learning experience on cell signaling and molecular techniques, collaboration strategies and leadership styles, the center’s exemplary way of collecting tissue samples from patients for research, amazing new colleagues, living in San... Read more
CCBIO PI Donald Gullberg recently returned from an inspiring conference in China, where he was invited speaker for the third National Conference of the Chinese Society of Matrix Biology.
The annual public research event by the scientific and research community in Bergen, the Research Fair ('Forskningstorget'), took this year place September 21st and 22nd. The Bergen Gynecologic Research Group took responsibility for the CCBIO stand this year, and attracted great interest both from adults and the actual target audience, kids and youth.
October 3rd 2018, CCBIO hosted a special seminar titled "The Importance of Mentoring for Career Development", where panellists Marsha A. Moses (Harvard Medical School/Boston Children’s Hospital), Roopali Roy (Harvard Medical School/Boston Children’s Hospital), Roland Jonsson (Faculty of Medicine/UiB) and Anne Blanchard (SVT/CCBIO) discussed mentoring in different forms and settings, and provided... Read more
As the first two weeks of the CCBIO/Harvard Long Course on Cancer-Related Vascular Biology are completed, the attending students report to be greatly inspired by the Harvard scholars who are teaching most classes. This course reflects the INTPART collaboration between CCBIO and the Vascular Biology Program at Boston Children´s Hospital and Harvard Medical School.
19th September 2018, CCBIO hosted a Special Seminar on the issue of scientific excellence. Speakers Bruce Zetter (Harvard Medical School/Boston Children's Hospital), Merle Jacob (Lund University) as well as Lars A. Akslen (CCBIO) and Roger Strand (SVT/CCBIO) discussed different ways to conceptualise and achieve excellence, leaving the audience both inspired and a little thought-provoked.

Pages